Introduction Following the implementation of the provision of lifelong antiretroviral therapy to all HIV-positive pregnant or breastfeeding women for prevention of mother-to-child transmission (PMTCT) of HIV by the Kingdom of Lesotho in 2013, we assessed the effectiveness of this approach by evaluating 24-month HIV-free survival among HIV-exposed infants (HEIs). Methods We conducted a prospective observational cohort study that enrolled HIV-positive and HIV-negative pregnant women, with follow-up of women and their infants for 24 months after delivery. Participant recruitment started in June 2014 and follow-up ended in September 2018. Trained nurses collected study information through patient interviews and chart abstraction at enrolme...
Background Although 1.3 million women with HIV give birth annually, care and outcomes for HIVexposed...
Background. Human immunodeficiency virus (HIV)-infected pregnant women increasingly receive antiretr...
BACKGROUND: Assumptions about survival of HIV-infected children in Africa without antiretroviral the...
Introduction Following the implementation of the provision of lifelong antiretroviral therapy to all...
Introduction Population-based HIV-free survival at 18–24 months of age among HIV-exposed infants in...
The number of new pediatric HIV-1 infections is reducing globally as services for the prevention of ...
IntroductionPopulation-based HIV-free survival at 18-24 months of age among HIV-exposed infants in h...
Lifelong antiretroviral therapy (ART) provision to all pregnant HIV-positive women (“Option B+”) has...
Background Lifelong antiretroviral therapy (ART) reduces mother-to-child HIV transmission (MTCT) an...
BACKGROUND:Lifelong antiretroviral therapy (ART) reduces mother-to-child HIV transmission (MTCT) and...
BACKGROUND: Lifelong antiretroviral therapy (ART) is now recommended for all human immunodeficiency ...
YesDespite being a preventable disease, pediatric HIV infection continues to be a public health conc...
ObjectivesHighly active antiretroviral therapy (HAART) provision to eligible HIV-infected pregnant a...
OBJECTIVE: To assess morbidity and mortality in HIV-exposed uninfected (HEU) childr...
Background: Since 1999 GHESKIO, a large voluntary counseling and HIV testing center in Port-au-Princ...
Background Although 1.3 million women with HIV give birth annually, care and outcomes for HIVexposed...
Background. Human immunodeficiency virus (HIV)-infected pregnant women increasingly receive antiretr...
BACKGROUND: Assumptions about survival of HIV-infected children in Africa without antiretroviral the...
Introduction Following the implementation of the provision of lifelong antiretroviral therapy to all...
Introduction Population-based HIV-free survival at 18–24 months of age among HIV-exposed infants in...
The number of new pediatric HIV-1 infections is reducing globally as services for the prevention of ...
IntroductionPopulation-based HIV-free survival at 18-24 months of age among HIV-exposed infants in h...
Lifelong antiretroviral therapy (ART) provision to all pregnant HIV-positive women (“Option B+”) has...
Background Lifelong antiretroviral therapy (ART) reduces mother-to-child HIV transmission (MTCT) an...
BACKGROUND:Lifelong antiretroviral therapy (ART) reduces mother-to-child HIV transmission (MTCT) and...
BACKGROUND: Lifelong antiretroviral therapy (ART) is now recommended for all human immunodeficiency ...
YesDespite being a preventable disease, pediatric HIV infection continues to be a public health conc...
ObjectivesHighly active antiretroviral therapy (HAART) provision to eligible HIV-infected pregnant a...
OBJECTIVE: To assess morbidity and mortality in HIV-exposed uninfected (HEU) childr...
Background: Since 1999 GHESKIO, a large voluntary counseling and HIV testing center in Port-au-Princ...
Background Although 1.3 million women with HIV give birth annually, care and outcomes for HIVexposed...
Background. Human immunodeficiency virus (HIV)-infected pregnant women increasingly receive antiretr...
BACKGROUND: Assumptions about survival of HIV-infected children in Africa without antiretroviral the...